Compare BRX & RGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | BRX | RGEN |
|---|---|---|
| Founded | 2011 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Real Estate Investment Trusts | Medical/Dental Instruments |
| Sector | Real Estate | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 8.1B | 8.2B |
| IPO Year | 2013 | N/A |
| Metric | BRX | RGEN |
|---|---|---|
| Price | $25.82 | $162.92 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 11 | 10 |
| Target Price | $29.82 | ★ $174.90 |
| AVG Volume (30 Days) | ★ 3.2M | 701.7K |
| Earning Date | 02-09-2026 | 10-28-2025 |
| Dividend Yield | ★ 4.77% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 1.08 | 0.03 |
| Revenue | ★ $1,346,289,000.00 | $707,890,000.00 |
| Revenue This Year | $7.62 | $17.84 |
| Revenue Next Year | $4.41 | $12.57 |
| P/E Ratio | ★ $23.86 | $6,381.36 |
| Revenue Growth | 5.75 | ★ 11.74 |
| 52 Week Low | $22.29 | $102.97 |
| 52 Week High | $28.61 | $182.52 |
| Indicator | BRX | RGEN |
|---|---|---|
| Relative Strength Index (RSI) | 48.23 | 55.66 |
| Support Level | $25.49 | $156.01 |
| Resistance Level | $26.08 | $165.02 |
| Average True Range (ATR) | 0.40 | 4.42 |
| MACD | 0.09 | -0.73 |
| Stochastic Oscillator | 74.92 | 51.63 |
Brixmor Property Group Inc is a real estate investment trust based in the United States. The company owns and operates a portfolio of grocery-anchored community and neighborhood shopping centers across the United States. It leases its rentable areas to retailers, restaurants, theatres, entertainment venues, and fitness centers, with the company's tenants consisting of large department stores, discount retailers, and grocery stores. The company is an internally managed REIT. The company operates in Florida, Texas, California, New York, Pennsylvania, Illinois, New Jersey, Georgia, North Carolina, Michigan, Ohio and other states.
Repligen, headquartered in Waltham, Massachusetts, is a global life sciences company that develops and sells bioprocessing equipment and supplies used in the manufacturing of biologic drugs, including monoclonal antibodies, recombinant proteins, vaccines, and cell and gene therapies. Its customers include biopharmaceutical companies, contract development and manufacturing organizations, or CDMOs, and other life science companies. It sells four main product categories: filtration (including fluid management) is the largest category and was 58% of 2024 revenue, while chromatography, proteins, and process analytics were 19%, 12%, and 9%, respectively. Customers in North America, Europe, and Asia Pacific contributed 44%, 37%, and 19% of revenue, respectively.